Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie L Dutton

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Biopolymers|December 17, 2009
Establishing regiocontrol of disulfide bond isomers of alpha-conotoxin ImI via the synthesis of N-to-C cyclic analogsChristopher J Armishaw, Julie L Dutton, David J Craik, et al.
The Journal of Biological Chemistry|October 12, 2002
A new level of conotoxin diversity, a non-native disulfide bond connectivity in alpha-conotoxin AuIB reduces structural definition but increases biological activityJulie L Dutton, Paramjit S Bansal, Ron C Hogg, et al.
Human Vaccines & Immunotherapeutics|September 1, 2016
An escalating dose study to assess the safety, tolerability and immunogenicity of a Herpes Simplex Virus DNA vaccine, COR-1Julie L Dutton, Wai-Ping Woo, Janin Chandra, et al.
The Journal of Biological Chemistry|August 26, 2004
Conserved structural and sequence elements implicated in the processing of gene-encoded circular proteinsJulie L Dutton, Rosemary F Renda, Clement Waine, et al.
Plos One|October 8, 2013
A novel DNA vaccine technology conveying protection against a lethal herpes simplex viral challenge in miceJulie L Dutton, Bo Li, Wai-Ping Woo, et al.
Journal of Medicinal Chemistry|March 21, 2003
Synthesis, structure elucidation, in vitro biological activity, toxicity, and Caco-2 cell permeability of lipophilic analogues of alpha-conotoxin MIIJoanne T Blanchfield, Julie L Dutton, Ronald C Hogg, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 7, 2017
DNA Vaccine Encoding HPV16 Oncogenes E6 and E7 Induces Potent Cell-mediated and Humoral Immunity Which Protects in Tumor Challenge and Drives E7-expressing Skin Graft RejectionJanin Chandra, Julie L Dutton, Bo Li, et al.
Plos One|December 18, 2019
Immune responses to a HSV-2 polynucleotide immunotherapy COR-1 in HSV-2 positive subjects: A randomized double blinded phase I/IIa trialJanin Chandra, Wai-Ping Woo, Julie L Dutton, et al.
Vaccine|June 1, 2026
Safety, immunogenicity, and dose ranging of a bivalent respiratory syncytial virus and human metapneumovirus glycoprotein F-molecular clamp vaccine candidate in older adults: 1-month interim analysis of an ongoing randomised, observer-blind, placebo- and active-controlled, phase 1 trialGiovanni Della Cioppa, Nischal Sahai, Vincent Dodeur, et al.
Plos Pathogens|July 17, 2025
A second-generation molecular clamp stabilised bivalent candidate vaccine for protection against diseases caused by respiratory syncytial virus and human metapneumovirusAndrew Young, Sharada Kolekar, Carlos Alvarez Mendoza, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Biopolymers|December 17, 2009
Establishing regiocontrol of disulfide bond isomers of alpha-conotoxin ImI via the synthesis of N-to-C cyclic analogsChristopher J Armishaw, Julie L Dutton, David J Craik, et al.
The Journal of Biological Chemistry|October 12, 2002
A new level of conotoxin diversity, a non-native disulfide bond connectivity in alpha-conotoxin AuIB reduces structural definition but increases biological activityJulie L Dutton, Paramjit S Bansal, Ron C Hogg, et al.
Human Vaccines & Immunotherapeutics|September 1, 2016
An escalating dose study to assess the safety, tolerability and immunogenicity of a Herpes Simplex Virus DNA vaccine, COR-1Julie L Dutton, Wai-Ping Woo, Janin Chandra, et al.
The Journal of Biological Chemistry|August 26, 2004
Conserved structural and sequence elements implicated in the processing of gene-encoded circular proteinsJulie L Dutton, Rosemary F Renda, Clement Waine, et al.
Plos One|October 8, 2013
A novel DNA vaccine technology conveying protection against a lethal herpes simplex viral challenge in miceJulie L Dutton, Bo Li, Wai-Ping Woo, et al.
Journal of Medicinal Chemistry|March 21, 2003
Synthesis, structure elucidation, in vitro biological activity, toxicity, and Caco-2 cell permeability of lipophilic analogues of alpha-conotoxin MIIJoanne T Blanchfield, Julie L Dutton, Ronald C Hogg, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 7, 2017
DNA Vaccine Encoding HPV16 Oncogenes E6 and E7 Induces Potent Cell-mediated and Humoral Immunity Which Protects in Tumor Challenge and Drives E7-expressing Skin Graft RejectionJanin Chandra, Julie L Dutton, Bo Li, et al.
Plos One|December 18, 2019
Immune responses to a HSV-2 polynucleotide immunotherapy COR-1 in HSV-2 positive subjects: A randomized double blinded phase I/IIa trialJanin Chandra, Wai-Ping Woo, Julie L Dutton, et al.
Vaccine|June 1, 2026
Safety, immunogenicity, and dose ranging of a bivalent respiratory syncytial virus and human metapneumovirus glycoprotein F-molecular clamp vaccine candidate in older adults: 1-month interim analysis of an ongoing randomised, observer-blind, placebo- and active-controlled, phase 1 trialGiovanni Della Cioppa, Nischal Sahai, Vincent Dodeur, et al.
Plos Pathogens|July 17, 2025
A second-generation molecular clamp stabilised bivalent candidate vaccine for protection against diseases caused by respiratory syncytial virus and human metapneumovirusAndrew Young, Sharada Kolekar, Carlos Alvarez Mendoza, et al.
Pageof 1